PRESS RELEASE published on 01/25/2023 at 11:49, 3 years 5 months ago Halfords Group PLC: Director/PDMR Shareholding
PRESS RELEASE published on 01/18/2023 at 16:13, 3 years 5 months ago Halfords Group PLC: Holding(s) in Company
PRESS RELEASE published on 01/12/2023 at 08:00, 3 years 5 months ago Halfords Group PLC: Q3 Trading Update: Financial Year 2023
Published on 06/26/2026 at 14:05, 1 hour 20 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 1 hour 25 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 2 hours 25 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 2 hours 40 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:17, 7 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 06/26/2026 at 15:17, 8 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Published on 06/26/2026 at 15:16, 9 minutes ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc
Published on 06/26/2026 at 07:00, 8 hours 25 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 8 hours 25 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
